高管在增长与风险信号混合的情况下出售Tempus AI股票。 
Executive sells Tempus AI shares amid mixed signals on growth and risk.
2026年2月19日至20日,Tempus AI(NASDAQ:TEM)看到内幕出售,一名执行副总裁和CFO James William Rogers通过以59.05至75.00美元的价格出售股份来减少股本。 On February 19–20, 2026, Tempus AI (NASDAQ:TEM) saw insider selling, with an executive vice president and CFO James William Rogers reducing stakes by selling shares at prices between $59.05 and $75.00. 股票在2月20日收盘时的58.37美元,下跌1.59美元,交易量高达788万股. The stock closed at $58.37 on February 20, down $1.59, with heavy volume of 7.88 million shares. 尽管公司内部销售量很大,但该公司的股价仍因在肿瘤学、心脏病学和心理健康方面推出新的AI工具而获得动力,得到Mizuho和Robert W. Baird的积极分析家评价的支持。 Despite the insider sales, the company’s stock gained momentum from new AI tool launches in oncology, cardiology, and mental health, supported by positive analyst ratings from Mizuho and Robert W. Baird. Tempus AI,价值10.38亿美元,根据《公认会计原则》仍然无利可图,债务与股本比率很高,贸易低于关键的移动平均数,从而增加了下行风险。 Tempus AI, valued at $10.38 billion, remains unprofitable under GAAP, carries a high debt-to-equity ratio, and trades below key moving averages, raising downside risk. 协商一致的评分是“等待”,目标价格为85.92美元。 The consensus rating is “Hold” with a target price of $85.92.
